藥物安全檢測和藥物安全軟體市場規模、佔有率、成長分析、按功能、按部署模式、按最終用戶、按地區 - 產業預測，2024-2031年

2022年全球藥物安全檢測和藥物安全軟體市場規模為1.823億美元，從2023年的1.9433億美元成長到2031年的3.2404億美元，預計在預測期（2024-2031）年複合成長率為 10.5%。

全球藥物安全檢測和藥物安全軟體市場由目的是加強藥物不良反應（ADR）和其他安全問題的追蹤、分析和報告的專門程序組成，特別是在羅馬尼亞，它對醫療保健提供者和監管機構變得越來越重要。這些軟體工具可以有效收集、管理和分析各種藥物安全資料，幫助製藥公司和醫療保健專業人員監控藥物有效性和副作用。識別潛在風險和新趨勢，以促進及時干涉和風險緩解策略。這些解決方案的主要使用者包括領先的藥物安全檢測提供者、業務流程外包（BPO）公司和合約委外研發機構（CRO）。隨著市場的發展，它將受到多種動態的影響，例如ADR發生率的上升和組織間外包趨勢的上升，預計這將推動採用率的提高。此外，FDA 和 EMEA 等監管機構推動更嚴格的藥品安全標準，進一步刺激該行業的成長。因此，藥物安全檢測和藥物安全軟體市場前景光明，其特點是由於對安全藥物治療實踐和有效管理藥物相關風險的需求而顯著擴張。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• PESTEL分析
• 總體經濟指標
• 貿易分析
• Start-Ups分析
• 供應鏈分析
• 價格分析

藥物安全檢測與藥物安全軟體市場：依功能分類

• 不良事件通報軟體
• 藥品安全審核軟體
• 問題追蹤軟體
• 完全整合的軟體

藥物安全檢測與藥物安全軟體市場：依部署模式

• 本地
• 雲端

藥物安全檢測和藥物安全軟體市場：依最終用戶分類

• 製藥和生物技術公司
• 合約調查機構
• 業務流程外包（BPO）
• 其他

藥物安全檢測和藥物安全軟體市場規模：依地區

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 阿拉伯聯合大公國國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Oracle Corporation
• Veeva Systems Inc.
• AB-Cube
• ArisGlobal

Global Pharmacovigilance and Drug Safety Software Market size was valued at USD 182.3 Million in 2022 poised to grow from USD 194.33 Million in 2023 to USD 324.04 Million by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

The global pharmacovigilance and drug safety software market, which consists of specialized programs aimed at enhancing the tracking, analysis, and reporting of Adverse Drug Reactions (ADRs) and other safety issues, is increasingly vital for healthcare providers and regulatory agencies, particularly in Romania. These software tools enable efficient collection, management, and analysis of extensive data concerning drug safety, assisting pharmaceutical companies and healthcare professionals in monitoring medication effectiveness and side effects. By identifying potential risks and emerging trends, they facilitate timely interventions and risk mitigation strategies. Primary users of these solutions include large pharmacovigilance providers, business process outsourcing (BPO) firms, and contract research organizations (CROs). As the market evolves, it is influenced by multiple dynamics, including the rising incidence of ADRs and the growing trend of outsourcing among organizations, which is expected to propel adoption rates. Moreover, increased regulatory scrutiny from agencies such as the FDA and EMEA demanding heightened safety standards in pharmaceuticals is further fueling growth in this sector. Consequently, the pharmacovigilance and drug safety software market is poised for a promising future, characterized by significant expansion driven by the necessity for safe medication practices and the effective management of drug-related risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacovigilance And Drug Safety Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacovigilance And Drug Safety Software Market Segmental Analysis

Global Pharmacovigilance and Drug Safety Software Market is segmented by Function, Deployment Mode, End User and region. Based on Function, the market is segmented into Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software Based on Deployment Mode, the market is segmented into On Premise and Cloud. Based on end user, the market is segmented into Pharma and Biotech Companies, Contract Research Organizations, Business Process Outsourcing and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Pharmacovigilance And Drug Safety Software Market

The escalating demand for pharmacovigilance and drug safety software is primarily propelled by stringent global regulatory frameworks enforced by authorities such as the FDA and EMA. These regulations mandate rigorous adverse event reporting and continuous drug safety monitoring, compelling pharmaceutical companies to adopt reliable software solutions that streamline compliance processes. As the drug development landscape becomes increasingly complex, the need for scalable and effective pharmacovigilance systems intensifies, enabling firms to efficiently manage regulatory obligations, mitigate risks, and enhance patient safety. This growing emphasis on regulatory adherence not only drives innovations in software development but also positions pharmacovigilance solutions as indispensable assets in the pharmaceutical industry.

Restraints in the Global Pharmacovigilance And Drug Safety Software Market

The Global Pharmacovigilance and Drug Safety Software market faces significant restraints due to the complex integration of novel software with existing systems and workflows. This challenge often leads to disruptions in operations, as organizations grapple with data migration issues to ensure compatibility with older systems that may lack modern efficiencies. Additionally, the high costs associated with advanced solutions deter many companies from adopting these technologies, resulting in prolonged implementation timelines. Consequently, the reluctance to invest in and transition to more effective pharmacovigilance tools curtails market growth, as businesses weigh the operational hassles against the benefits of new solutions.

Market Trends of the Global Pharmacovigilance And Drug Safety Software Market

The global pharmacovigilance and drug safety software market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning technologies. These advancements facilitate superior data analytics, enabling more efficient automation of adverse event reporting and enhanced predictive capabilities. As a result, stakeholders can achieve improved accuracy and efficacy in drug safety management, leading to better compliance with regulatory standards. This trend reflects a broader shift towards digitization and automation within the healthcare sector, fostering a proactive approach to drug safety and risk management, ultimately ensuring the protection of public health and enhancing pharmaceutical innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis
• Startup Analysis
• Supply Chain Analysis
• Pricing Analysis

Global Pharmacovigilance and Drug Safety Software Market Size by Function & CAGR (2024-2031)

• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

Global Pharmacovigilance and Drug Safety Software Market Size by Deployment Mode & CAGR (2024-2031)

• On Premise
• On Cloud

Global Pharmacovigilance and Drug Safety Software Market Size by End User & CAGR (2024-2031)

• Pharma and Biotech Companies
• Contract Research Organizations
• Business Process Outsourcing
• Other

Global Pharmacovigilance and Drug Safety Software Market Size & CAGR (2024-2031)

• North America, (Function, Deployment Mode, End User)
  • US
  • Canada
• Europe, (Function, Deployment Mode, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Function, Deployment Mode, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Function, Deployment Mode, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Function, Deployment Mode, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veeva Systems Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AB-Cube
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArisGlobal
  • Company Overview
  • Business Segment Overview